Although circulating levels of insulin, IGF-1, GH and LEP in relation to breast cancer have been well studied, less is known about how germline variation in the insulin, IGF, GH, and LEP signaling pathways may affect risk of breast cancer. This evidence concerns the gene LEP and breast carcinoma.